NCT00527657 2018-11-14Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma PatientsM.D. Anderson Cancer CenterPhase 1 Completed17 enrolled
NCT00072345 2013-01-18Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV MelanomaMemorial Sloan Kettering Cancer CenterPhase 2 Completed